News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
33,526 Results
Type
Article (1291)
Company Profile (3)
Press Release (32232)
Section
Business (15437)
Career Advice (98)
Deals (1944)
Drug Development (3697)
FDA (519)
Job Trends (677)
News (20596)
Policy (1009)
Tag
Academia (46)
Accelerated approval (1)
Adcomms (1)
Allergies (4)
Alliances (1079)
ALS (5)
Alzheimer's disease (74)
Antibody-drug conjugate (ADC) (3)
Approvals (547)
Artificial intelligence (6)
Automation (1)
Bankruptcy (13)
Best Places to Work (659)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (3)
Bladder cancer (14)
Breast cancer (21)
Cancer (192)
Cardiovascular disease (18)
Career advice (98)
CAR-T (3)
Cell therapy (10)
Cervical cancer (1)
Clinical research (3279)
Collaboration (35)
Compensation (10)
COVID-19 (65)
CRISPR (1)
C-suite (3)
Cystic fibrosis (3)
Data (314)
Depression (10)
Diabetes (18)
Diagnostics (276)
Digital health (4)
Drug discovery (7)
Drug pricing (3)
Duchenne muscular dystrophy (9)
Earnings (14206)
Editorial (1)
Events (4901)
Executive appointments (13)
FDA (755)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (21)
Gene editing (1)
Generative AI (1)
Gene therapy (16)
GLP-1 (33)
Government (94)
Guidances (142)
Healthcare (888)
HIV (3)
Huntington's disease (2)
IgA nephropathy (9)
Immunology and inflammation (10)
Immuno-oncology (1)
Indications (6)
Infectious disease (77)
Inflammatory bowel disease (4)
Influenza (3)
Intellectual property (6)
Interviews (9)
IPO (1451)
Job creations (55)
Job search strategy (94)
Labor market (2)
Layoffs (14)
Legal (148)
Liver cancer (3)
Lung cancer (34)
Lymphoma (26)
Manufacturing (10)
MASH (11)
Medical device (801)
Medtech (804)
Mergers & acquisitions (530)
Metabolic disorders (50)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (4)
Neuroscience (121)
NextGen: Class of 2025 (184)
Non-profit (59)
Now hiring (1)
Obesity (22)
Opinion (3)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (11)
Parkinson's disease (7)
Patents (14)
Patient recruitment (9)
Peanut (2)
People (1059)
Pharmacy benefit managers (1)
Phase I (721)
Phase II (1359)
Phase III (1437)
Pipeline (460)
Policy (2)
Postmarket research (182)
Preclinical (318)
Press Release (1)
Prostate cancer (9)
Psychedelics (4)
Radiopharmaceuticals (5)
Rare diseases (14)
Real estate (145)
Regulatory (890)
Reports (5)
Research institute (44)
Resumes & cover letters (5)
RSV (5)
Schizophrenia (11)
Series A (3)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (82)
Supply chain (2)
Vaccines (15)
Venture capital (1)
Weight loss (12)
Women's health (4)
Date
Today (6)
Last 7 days (21)
Last 30 days (95)
Last 365 days (2098)
2025 (1601)
2024 (2310)
2023 (2522)
2022 (2764)
2021 (2908)
2020 (2353)
2019 (1780)
2018 (1322)
2017 (1101)
2016 (786)
2015 (1160)
2014 (737)
2013 (443)
2012 (514)
2011 (556)
2010 (581)
Location
Africa (101)
Alabama (5)
Arizona (13)
Arkansas (1)
Asia (2234)
Australia (266)
California (606)
Canada (172)
China (38)
Colorado (43)
Connecticut (36)
Delaware (25)
Europe (4079)
Florida (83)
Georgia (26)
Illinois (44)
India (1)
Indiana (40)
Japan (23)
Kansas (4)
Kentucky (1)
Louisiana (7)
Maine (6)
Maryland (67)
Massachusetts (378)
Michigan (15)
Minnesota (34)
Missouri (5)
Montana (3)
Nevada (4)
New Hampshire (6)
New Jersey (230)
New Mexico (1)
New York (142)
North Carolina (96)
Northern California (288)
Ohio (13)
Pennsylvania (133)
Puerto Rico (1)
South America (108)
South Carolina (1)
Southern California (231)
Tennessee (5)
Texas (55)
United States (2190)
Utah (22)
Virginia (10)
Washington D.C. (3)
Washington State (70)
Wisconsin (5)
33,526 Results for "104".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
October 13, 2025
·
8 min read
Press Releases
Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104
September 18, 2025
·
8 min read
Press Releases
Reunion Neuroscience Announces First Patient Dosed in REKINDLE Phase 2 Clinical Trial of RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses
October 1, 2025
·
5 min read
Press Releases
Grace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104
August 28, 2025
·
9 min read
Press Releases
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
September 5, 2025
·
3 min read
Press Releases
Reunion Neuroscience Announces Final Closing of its Series A Financing and Plans to Advance RE104 into Clinical Development for the Treatment of Generalized Anxiety Disorder (GAD)
September 17, 2025
·
5 min read
Press Releases
Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs
September 29, 2025
·
13 min read
Press Releases
A Landmark Pivotal Study Applying Precision Medicine to Psychiatry with Denovo’s DB104 (liafensine) for Treatment-Resistant Depression Published in JAMA Psychiatry
September 11, 2025
·
4 min read
Press Releases
Reunion Neuroscience Announces Publication of RE104 Phase 1 Data in The Journal of Clinical Psychopharmacology
July 23, 2025
·
5 min read
Press Releases
Kiora Pharmaceuticals Granted U.S. Patent Expanding Protection for KIO-104 in the Treatment of Ocular Disease
July 22, 2025
·
4 min read
1 of 3,353
Next
